More On

Borden leads Cooley team in Horizon Pharma’s acquisition of Vidara Therapeutics

The deal, expected to close by mid-2014, positions the company for future acquisitions

Cooley LLP's M&A head Barbara L. Borden

When Horizon Pharma Inc. acquired Vidara Therapeutics International Ltd. for $660 million, it tapped Cooley and its M&A head Barbara L. Borden to spearhead the deal.

Borden’s team included partners Kay Chandler, Sean Clayton, Mark Hrenya and Mischi a Marca; special counsel Barry Graynor, Eric Kauffman and Michelle Lara; and associates Wade Andrews, Ben Beerle, Scott Tanner and Matt Robbins. Partner Jackie Grise (antitrust); partner Natasha Leskovsek (life sciences); of counsel John Steines and associate Michael Baker (tax) provided critical support, according to the firm.

Contributing Author

author image

Amy I. Stickel

Amy I. Stickel has extensive experience covering the legal, financial and pharmaceutical industries as a writer and editor. A past managing editor of Corporate Legal Times and...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.